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Abstract 
AIM 
The aim of this study was to determine the hindrances and 
obstacles faced by doctors working in Khartoum Teaching 
Hospital’s out patient clinics in conducting a proper evaluation of 
reproductive age women presenting with non pregnancy related 
Abnormal Vaginal Bleeding. 
METHODOLOGY 
Doctors were observed to what extent they adhered to an 
internationally standardized protocol for the evaluation of these 
women, using a Template Designed Check List .They were then 
given a Questionnaire to be filled by them which highlighted the 
main obstacles/hindrances faced by them in the proper evaluation 
of this group of patients. 
RESULTS 
The majority of the doctors were found to be moderately adherent 
to the internationally standardized protocol in the history taking. 
However they were found to be far from the protocol as regards 
the physical examination and investigations. The major 
obstacles/hindrances highlighted were found to be lack of facilities, 
staff and ample time . 
CONCLUSION 
In conclusion the approach of doctors requires to be modified, so 
that the quality of care provided to this group of patients may be 
improved.      
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 ﻣﻠﺨѧѧﺺ اﻷﻃﺮوﺣѧѧﺔ
اﻟﻬﺪف ﻣﻦ هﺬﻩ اﻟﺪراﺳﺔ آﺎﻧﺖ ﻟﺘﻮﺿﻴﺢ اﻟﺼﻌﻮﺑﺎت اﻟﺘﻲ ﺗﻌﻴﻖ اﻷﻃﺒﺎء اﻟﺬﻳﻦ ﻳﻌﻤﻠﻮن ﻓﻲ اﻟﻌﻴﺎدات 
اﻟﺨﺎرﺟﻴﺔ اﻟﻤﺨﺘﻠﻔﺔ ﺑﻤﺴﺘﺸﻔﻴﺎت اﻟﺨﺮﻃﻮم اﻟﺘﻌﻠﻴﻤﻴﺔ ﻟﺘﻘﻴﻴﻤﻬﻢ ﻟﺤﺎﻻت اﻟﻨﺰﻳﻒ اﻟﻤﻬﺒﻠﻲ ﻏﻴﺮ اﻟﻌﺎدي 
  .اﻟﻐﻴﺮ ﻣﺘﻌﻠﻖ ﺑﺎﻟﺤﻤﻞ اﻟﺬي ﻳﺤﺪث ﻟﻠﻨﺴﺎء ﻓﻲ ﺳﻦ اﻹﻧﺠﺎب
ﺪى آﺎﻧﻮا ﻳﻘﻴﻤﻮن ﻣﺜﻞ هﺬﻩ اﻟﺤﺎﻻت وﻓﻘﺎ ﻟﻠﺒﺮﺗﻮآﻮل اﻟﻘﻴﺎﺳﻲ اﻟﻌﺎﻟﻤﻲ اﻟﻤﺒﻨﻲ وﻗﺪ ﺗﻼﺣﻆ إﻟﻰ أي ﻣ
ﻣﺎ هﻲ "وﻣﻦ ﺛﻢ ﺗﻢ اﺳﺘﺒﻴﺎن اﻷﻃﺒﺎء ﻟﺘﻮﺿﻴﺢ وﺟﻬﺔ ﻧﻈﺮ آﻞ ﻣﻨﻬﻢ ﻋﻠﻰ ﺣﺪﻩ . ﻋﻠﻰ اﻷﺳﺲ اﻟﻌﻠﻤﻴﺔ
اﻟﺼﻌﻮﺑﺎت واﻟﻤﻌﻮﻗﺎت اﻟﺘﻲ ﺗﻮاﺟﻬﻬﻢ ﻓﻲ اﻟﺘﻘﻴﻴﻢ اﻷﻣﺜﻞ وﺻﻮﻻ ﻟﺘﻄﺒﻴﻖ اﻟﺒﺮوﺗﻮآﻮل اﻟﻘﻴﺎﺳﻲ 
  ".اﻟﻌﺎﻟﻤﻲ
أن اﻷﻏﻠﺒﻴﺔ اﻟﻌﻈﻤﻰ ﻣﻦ اﻷﻃﺒﺎء آﺎﻧﻮا ﻳﻘﻮﻣﻮن ﺑﺄﺧﺬ اﻟﺘﺎرﻳﺦ اﻟﻤﺮﺿﻰ ﺣﺴﺐ ﻧﺼﻮص  وﻗﺪ إﺗﻀﺢ 
وﻟﻜﻦ إﺗﻀﺢ أن ﻓﻴﻤﺎ ﻳﺨﺺ إﺗﺒﺎع اﻟﺪﻗﺔ ﻓﻲ اﻟﻜﺸﻒ اﻟﺴﺮﻳﺮي وﻋﻤﻞ .  اﻟﻘﻴﺎﺳﻲ اﻟﻌﺎﻟﻤﻲلاﻟﺒﺮوﺗﻮآﻮ
  . اﻟﻘﻴﺎﺳﻲ اﻟﻌﺎﻟﻤﻲلاﻟﻔﺤﻮﺻﺎت اﻟﻤﻨﺎﺳﺒﺔ ﻟﻬﺬﻩ اﻟﺤﺎﻻت ﻓﻘﺪ آﺎﻧﺖ ﺑﻌﻴﺪة ﻋﻦ ﻧﺼﻮص اﻟﺒﺮوﺗﻮآﻮ
  -:هﻲ آﺎﻧﺖ ﺗﻮاﺟﻪ اﻷﻃﺒﺎء اﻟﺘﻲاﻟﻜﺒﻴﺮة ﻗﺎت واﻟﻤﺸﺎآﻞ وﻗﺪ ﺗﻢ ﺗﺤﺪﻳﺪ اﻟﻤﻌﻮ
 .ﻋﺪم وﺟﻮد ﺑﻌﺾ اﻷﺟﻬﺰة اﻟﻜﺎﻓﻴﺔ ﻟﻠﻜﺸﻒ 
 .اﻟﻨﻘﺺ اﻟﺤﺎد ﻓﻲ اﻟﻘﻮة اﻟﻌﺎﻣﻠﺔ 
ﻋﺪم وﺟﻮد اﻟﻮﻗﺖ اﻟﻜﺎﻓﻲ اﻟﺬي ﻳﻤﻜﻦ اﻟﻄﺒﻴﺐ ﻣﻦ إﺟﺮاء اﻟﺒﺮوﺗﻮآﻮل اﻟﻤﻌﻨﻲ ﻟﻠﻮﺻﻮل  
 .ﻟﻠﺘﺸﺨﻴﺺ اﻟﺴﻠﻴﻢ
ﻳﺪ ﻣﻦ اﻟﺘﺤﺴﻴﻦ ﺑﺤﻴﺚ ﻳﺘﻤﻜﻨﻮا ﻣﻦ ﺗﺄدﻳﺔ وﻓﻲ اﻟﺨﺘﺎم ﻧﻮﺿﺢ أن ﻃﺮﻳﻘﺔ ﺗﻌﺎﻣﻞ اﻷﻃﺒﺎء ﺗﺤﺘﺎج إﻟﻰ ﻣﺰ
   . واﺟﺒﻬﻢ ﺑﻬﺪف ﺗﺤﺴﻴﻦ اﻟﻌﻨﺎﻳﺔ اﻟﺼﺤﻴﺔ اﻟﻤﻘﺪﻣﺔ ﻟﻬﺬﻩ اﻟﻤﺠﻤﻮﻋﺔ ﻣﻦ اﻟﻨﺴﺎء
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 Introduction 
Vaginal bleeding is one of the most common complaints of women 
presenting to the ED. Therefore, it is very important for the ED 
physician to have expertise in the initial evaluation and treatment 
of vaginal bleeding. Pregnancy-related causes of abnormal uterine 
bleeding must always be considered early in the differential 
diagnosis of any reproductive-age woman. Because the diagnosis 
of pregnancy always alters the approach to the patient with vaginal 
bleeding, a pregnancy test is imperative before proceeding to 
treatment. 
The causes of abnormal vaginal bleeding that are non-pregnancy 
related fall into two categories: 1) hormonal imbalance of 
oestrogen and/or progesterone, or 2) an anatomic lesion. 
Derangement of oestrogen-progesterone balance is most 
commonly due to anovulatory states and occurs at the extremes of 
a woman’s reproductive life.1 Anatomic lesions can cause severe 
bleeding and usually require histological identification.  
Although most episodes of abnormal vaginal bleeding do not 
cause acute medical complications, diagnosis and treatment are 
essential because menses is the main source of iron loss in the 
menstruating woman. Increased vaginal blood loss is the most 
common cause of iron-deficiency anaemia in women of 
reproductive age.2  
This review focuses on the different presentations of ABNORMAL 
VAGINAL BLEEDING in reproductive age women unrelated to 
pregnancy that present to out patient clinics with this complaint at 
 various K.T.H’s with an emphasis on how doctors working in these 
clinics initially evaluate these patients.  
 
Normal Menstruation 
In order to understand vaginal bleeding in the disease state, it is 
essential to have a detailed understanding of normal menstruation 
and the hormonal influences that are crucial to this process.  
The normal menstrual cycle depends on a complex interaction of 
hormonal events that have profound anatomical and physiological 
consequences. Normal menses is based on the relative amounts 
of oestrogen and progesterone, which, in turn, are regulated by the 
hypothalamus’ secretion of two releasing factors: luteinizing 
hormone (LH) and follicle-stimulating hormone (FSH). Oestrogen 
stimulation approximately six months prior to menarche initiates 
endocervical mucus production and desquamation of vaginal 
epithelial cells. Thus, prior to beginning true menstrual flow, 
peripubescent girls will begin to experience physiological 
leukorrhea.  
Each menstrual cycle is divided into three phases: proliferative 
(follicular), secretory (luteal), and menstrual. By convention, the 
first day of the menstrual bleeding cycle is considered day 1, and 
subsequent days are numbered serially until the next menstrual 
bleeding.  
 Proliferative Phase. The first phase of menses is called the 
proliferative phase because of the dramatic proliferation and 
growth of the endometrial wall of the uterus. FSH and LH stimulate 
the uterus to increase its wall thickness. This phase of the 
menstrual cycle varies the most in duration. It usually lasts about 
10 days.  
At the beginning of the menstrual cycle (approximately days 4 and 
5), the hypothalamus synthesizes and secretes gonadotropin-
releasing hormone, which stimulates the secretion of the 
gonadotropins LH and FSH from the pituitary gland. FSH 
stimulates the formation of about 1000 ovarian follicles in the 
ovaries during each menstrual cycle. FSH and LH cause the 
maturing follicles to produce and secrete three classes of sex 
steroids: estrogens, androgens, and progestins. 
Oestrogen, the most important sex steroid at the early stage of 
follicular development, provides the primary feedback inhibition to 
the pituitary gland and its secretion of FSH.9  
 A positive feedback 
mechanism also develops 
with the leading follicle—the 
graafian follicle. This follicle 
secretes the majority of 
estradiol. This oestrogen is 
the most potent, develops 
the most FSH and LH 
receptors, and secretes 
even more estradiol. 
Estradiol secretion peaks 
around the 14th day.5,10 The 
oestrogen levels also exert 
positive feedback on LH. 
Approximately 24-36 hours before ovulation, oestrogen levels rise 
sharply, causing a further decline of FSH and an LH peak. This LH 
surge in turn triggers ovulation.9 (See Figure 1.) 
The high oestrogen levels of the proliferative phase stimulate the 
growth of the endometrium from 1 mm at the time of menstruation 
to 5 mm at the time of ovulation.10 Another action of oestrogen 
during the proliferative phase is the synthesis of progesterone 
receptors.5  
The endometrial threshold is a theoretical representation of the 
amount of oestrogen stimulation required to prime the 
endometrium so that bleeding can occur.11 In other words, a 
certain amount of oestrogen must be present for a certain amount 
of time to sufficiently thicken the wall of endometrium. The amount 
of endometrial tissue produced during this phase is directly 
 proportional to the levels of circulating estrogen.9 Only oestrogen 
priming of the endometrium can produce bleeding; progesterone 
administration without oestrogen priming will not cause bleeding.8 
After ovulation, progesterone production increases, and the 
secretory phase begins.3  
Secretory Phase. The LH surge and subsequent ovulation caused 
by increased estradiol heralds the beginning of the secretory 
phase. The LH surge also causes production of progesterone in 
the dominant follicle 12-24 hours before ovulation.5,9 The 
increasing progesterone secretion plays a major role in both 
successful ovulation and development of the corpus luteum 
following ovulation.  
A smaller FSH surge also occurs and causes: 1) increased 
androgen production in the degenerating follicles; 2) progesterone 
production in the dominant follicle; 3) the remaining follicles to 
become atretic; and 4) an ovulatory stimulus. This ovulatory 
stimulus is accomplished by stimulating prostaglandin production 
essential for follicle rupture. Birth control pills inhibit FSH and LH 
secretion, thus neither the LH surge nor ovulation take place.9  
After ovulation, the graafian follicle develops and becomes the 
corpus luteum. It produces progesterone, which antagonizes the 
action of oestrogen by inducing enzymatic conversion of estradiol 
to estrone, a less potent oestrogen. Remember, oestrogen's action 
is to stimulate growth. Progesterone, therefore, indirectly halts the 
growth of the endometrium since it inhibits estrogen.9,11 
Progesterone causes the endometrial stroma to become compact, 
and secretory changes occur within the glands.3  
 The secretory phase begins on the day after ovulation, continues 
for 14 days, and is much more constant in duration than the more 
variable proliferative phase.5 The corpus luteum functions for 
approximately 14 days under LH stimulation, during which it 
gradually involutes if pregnancy has not occurred. Both oestrogen 
and progesterone levels then return to basal levels, initiating a 
cascade of events that culminates in menstruation.3,5,10 If 
fertilization and implantation occur, the trophoblast will begin to 
secrete b-hCG and maintain the function of the corpus luteum.  
Menstruation. Menstruation is due to oestrogen and progesterone 
withdrawal. The bleeding is self-limited because the endometrium 
responds in an orderly and progressive fashion in shedding down 
to the basal layers.3,8  
During menstruation, blood flow is facilitated by local fibrinolytic 
activity in the endometrial blood vessels.5 Cessation of menstrual 
bleeding, on the other hand, depends on clotting occurring at the 
disrupted end of the spiral endometrial arteries, prolonged 
vasoconstriction, and the active proliferation and regeneration of 
the endometrium.5  
If ovulation does not occur, an abnormal pattern of uterine 
bleeding results. This is because oestrogen's effects are not 
balanced by those of progesterone and, thus, unopposed 
estrogenic stimulation occurs. Bleeding then proceeds in a 
disordered fashion. Periods can be excessive in frequency and 
amount, or they may be infrequent and lighter at irregular 
intervals.5  
 Normal Menstrual Cycles 
The normal menstrual cycle is 21-35 days. Variability in the cycle 
occurs in the proliferative (follicular) phase; the secretory (luteal) 
phase is more consistent, lasting 12-14 days. Normal menstrual 
flow usually occurs over 2-6 days. Flow is usually heaviest for the 
first 1-3 days and then tapers off.3,10,12 The average blood loss per 
cycle is 20-60mL, with median expected blood loss approximately 
30-40 mL.3,5,13 Menstrual blood loss of 80 mL or more is 
considered excessive and results in a greater risk of iron-
deficiency anemia.10,13,14 Although there is patient-to-patient 
variability in the length, duration, and amount of menstrual blood 
loss, these parameters remain relatively constant for individuals 
from cycle to cycle. Usually, the only time a woman seeks medical 
advice for this problem is when she perceives a deviation from her 
norm.10  
 Terminology  
There are a number of terms used to describe vaginal bleeding 
that describe the quantity, frequency, or cause of the bleeding. 
Because a woman’s perception of blood loss is highly subjective, 
objective evaluation of these patients is difficult. For practical 
purposes any patient who complains of a change in her previously 
established “normal” menstrual pattern may be considered to 
have ABNORMAL VAGINAL BLEEDING. Some of the terms used 
to describe these pathological conditions require definition:  
1) Polymenorrhea: This is bleeding occurring at regular intervals 
of less than 21 days. 
2) Oligomenorrhea: This is bleeding occurring at regular intervals 
of more than 35 days but less than six months. 
3) Menorrhagia (Hypermenorrhea): This is excessive or 
prolonged bleeding occurring at regular intervals. 
4) Metrorrhagia: This is bleeding occurring at irregular intervals. 
5) Menometrorrhagia: This is excessive or prolonged bleeding 
occurring at irregular intervals. This is sometimes referred to as 
Metromenorrhagia.  
6) Intermenstrual Bleeding: This is bleeding occurring between 
regular menstrual intervals. This may also be referred to as 
Breakthroughbleeding. 
7) Amenorrhea: This is the absence of menstruation for a period 
of more than 6 months. 
 Aetiologies of Abnormal Vaginal Bleeding  
Abnormal vaginal bleeding takes place for a variety of reasons. 
Increased menstrual blood loss may be due to anovulatory or 
ovulatory disorders, chronic systemic illnesses, organic 
reproductive pathology, blood dyscrasias, anatomic lesions, or 
trauma. (See Table 1.) 
 
Table 1. Common Causes of Abnormal 
Uterine Bleeding at Different Ages 
Adolescence 
Anovulatory uterine bleeding, coagulation 
disorders,  
pregnancy-related causes, functional ovarian 
cysts, 
breakthrough bleeding, withdrawal bleeding 
Reproductive Age  
Pregnancy related causes, dysfunctional uterine 
bleeding, anatomic lesions, anticoagulant 
therapy, thyroid disease 
Perimenopausal Age 
Anatomic lesions, anovulatory dysfunctional 
uterine bleeding, bleeding disorders, liver 
disease, anticoagulant therapy 
 
 Dysfunctional Uterine Bleeding. Dysfunctional uterine bleeding 
(DUB) refers to abnormal vaginal bleeding that is usually hormonal 
in aetiology. This entity remains a common cause of abnormal 
vaginal bleeding. The hormonal abnormalities can be the result of 
endogenous abnormal hormone production or the result of 
exogenously given sex steroids (i.e., OCPs).  
As stated previously, the endometrial threshold is the amount of 
oestrogen stimulation required to prime the endometrium so that 
bleeding can occur. The pattern and magnitude of the abnormal 
bleeding is thought to depend on not only the level of circulating 
oestrogen, but also on the fluctuations that occur at that level. 
Women with low oestrogen levels are likely to have intermittent 
spotting and light bleeding. Women with higher levels of estrogens 
often have a prolonged interval of amenorrhea followed by 
excessive episodes of bleeding.5 If, for some reason, oestrogen 
levels are insufficient to reach the endometrial threshold, bleeding 
will not occur.8,11  
There are two variations of oestrogen breakthrough bleeding. The 
first is associated with oestrogen levels that are well above the 
endometrial threshold required to prime the endometrium. 
Oestrogen stimulates the growth of the endometrium, while 
progesterone matures the endometrium and inhibits the 
endometrial growth effects of oestrogen. In anovulatory states, with 
no progesterone inhibition, unopposed estrogenic stimulation 
causes the endometrial lining to become quite thick and vascular. 
Since ovulation has not occurred, and, thus, no progesterone is 
being produced, the bleeding usually seen in normal menstruation 
does not occur. Areas of endometrium outgrow their hormonal 
 support and degenerate, causing irregular and prolonged 
bleeding.8 Rather than an orderly shedding of the endometrium, 
the thick endometrium becomes friable and intermittently breaks 
down to bleed. The resultant bleeding due to inefficient 
endometrial shedding may be prolonged, profuse, and irregular. 
This type of anovulatory bleed is a very common cause of 
abnormal uterine bleeding in young women.11  
The other type of oestrogen breakthrough bleeding is associated 
with relatively low, but constant, levels of oestrogen that tend to 
hover at levels around the bleeding threshold. Portions of the 
endometrium degenerate and spotting occurs.  
Progesterone withdrawal bleeding occurs only after the 
endometrium has been primed with estrogenic stimulation. 
Progesterone alone cannot induce bleeding because it does not 
cause proliferation of the endometrium. When oestrogen therapy is 
continued as progesterone is withdrawn, progesterone withdrawal 
bleeding occurs. This type of bleeding is relatively uncommon.12  
When exogenous synthetic sex steroid hormones are 
administered, most commonly OCPs, abnormal vaginal bleeding 
can be seen due to a variety of mechanisms resulting in 
breakthrough bleeding or withdrawal.  
Breakthrough bleeding occurs more frequently on progestin-only 
pills or pills with low doses of oestrogen and progestin and is 
annoying enough that the OCPs are often discontinued.5 replacing 
them with a different pill formulation, usually one with a higher 
dose of oestrogen, may reduce breakthrough bleeding. 
 Breakthrough bleeding can indicate reduced birth-control efficacy, 
so additional contraception (if birth control is desired), such as a 
barrier method, should be advised until the bleeding resolves.14  
Intermenstrual bleeding is common when patients first begin OCPs 
but usually resolves within three months of starting the drug. 
Intermenstrual bleeding while on OCPs is usually due to missed 
pills or variable ingestion times. Patients should be carefully 
counseled about the importance of taking the OCP every day. 
Taking the pill at the same time each day decreases the frequency 
of breakthrough bleeding.14  
Drug interactions have also been implicated in breakthrough 
bleeding in patients on OCPs. The most common drugs causing 
breakthrough bleeding are anticonvulsants, such as phenytoin, 
phenobarbital, carbamazepine and, primidone, and some 
antibiotics, like penicillins, tetracylines and trimethoprim-
sulfamethoxazole. 
  
 Anatomic Pelvic Disease. Cervical Lesions. The vulva, vagina, 
and cervix may have abnormalities, such as tumours, infections, or 
lacerations.10 Lesions of the cervix can cause abnormal vaginal 
bleeding that must be differentiated from intrauterine sources. If 
present, cervical polyps will usually be visible within the cervical os 
and are usually erythematous, friable and painless. Their 
presenting symptom is commonly postcoital or intermenstrual 
bleeding.3 Cervical or vaginal condyloma can also be a source of 
bleeding. In addition, trauma to the cervix or vagina, especially with 
atrophic, postmenopausal mucosa, can be the source of vaginal 
bleeding.5  
Uterine Lesions. Benign lesions of the uterus are a much more 
common cause of abnormal uterine bleeding than malignancies.5 
Perimenopausal women frequently become metromenorrhagic 
because of anovulation, but in many cases this occurs in 
combination with anatomic lesions such as uterine fibroids, polyps, 
and neoplasia.5,14 Uterine leiomyomas or fibroids occur in 20-25% 
of women by age 40 and in up to 50% of women overall.14,15 The 
majority of leiomyomas are asymptomatic. About 30% of patients 
with leiomyomas complain of abnormal uterine bleeding. Fibroids 
are a common incidental finding, and the presence of fibroids does 
not indicate that they are the cause of the excessive bleeding until 
other causes have been ruled out.14 Large, intramural uterine 
leiomyomas can cause menorrhagia by enlarging the surface area 
of the endometrial cavity or by altering the uterine and endometrial 
vasculature.15 Submucosal and intraluminal polypoidal leiomyomas 
disrupt the endometrial vessels and are more likely to cause 
 abnormal uterine bleeding.5,16 The bleeding associated with 
leiomyomas is cyclic and can be profuse.3  
As with fibroids, adenomyosis is another cause of an enlarged 
uterus. Uterine adenomyosis occurs when endometrial tissue is 
imbedded in the myometrium and can contribute to abnormal 
uterine bleeding.5,16  
Endometriosis is a variable condition that undoubtedly may be 
accompanied by normal bleeding, but clinical evidence suggests 
that it is also associated with menorrhagia, though not 
frequently.16,17  
Endometrial polyps are most frequently encountered in women 
between the ages of 40 and 55 and may be found solitary or 
multiple, pedunculated or sessile.3  
Malignant tumours of the uterus become more common as age 
progresses. Endometrial carcinoma occurs most commonly 
between the ages of 50 and 75 years, although 20-25% of cases 
occur before menopause.5 Leiomyosarcoma must be suspected 
when menorrhagia does not respond to treatment and is 
associated with progressive uterine growth.18 One % of women, 
between ages 40 and 60 years, with presumed uterine leiomyomas 
with symptoms significant enough to warrant hysterectomy had a 
diagnosis of leiomyosarcoma postoperatively.5 Anatomical lesions 
are probably better diagnosed by hysteroscopy and ultrasound 
than by the traditional D&C. 1,17,19-30  
The presence of an IUD can produce intermenstrual bleeding. The 
IUD creates a foreign body reaction in the uterus that results in a 
 local inflammatory reaction in the endometrium and shows potent 
fibrinolytic activity.18,31 This bleeding is generally well-tolerated by 
the patient with proper reassurances. Other causes of abnormal 
uterine bleeding can coexist with the IUD. These should be 
considered if there is significant deviation from an established 
bleeding pattern from month to month.5 The duration and the 
amount of menstrual blood loss are increased by inert or copper-
containing IUDs. On the other hand, progesterone-containing IUDs 
diminish menstrual blood loss.15 Bleeding directly due to the IUD is 
relieved when the device is removed, often with the next cycle.5  
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 Literature Review 
                  The Clinical Approach 
EVALUATION (DIAGNOSIS) is an art in any of the disciplines of 
clinical medicine, and since time immemorial has been based on 
three main assumptions:  
1) HISTORY 
2) PHYSICAL EXAMINATION 
3) INVESTIGATIONS 
 
HISTORY 
Overview 
An adequate evaluation requires establishing a rapport during 
history taking. Enough time should be allowed for the patient to 
express herself and to tell her story to an interested listener who 
does not allow body language or facial expressions to imply 
disinterest or boredom. It is always wise to avoid cutting off the 
patient’s story as this may obscure important clues or problems 
which contributed to the visit. 
Initially this should be directed at providing a description of the 
pattern of abnormal menstrual bleeding as this will help to guide 
further evaluation. It is important to get some gauge of the severity 
 of the bleeding pattern. Actual blood loss is highly subjective but a 
general impression may be gained by ascertaining how many pads 
a patient is using and at what frequency these are changed. 
The physician should also be concerned about conditions other 
than purely somatic ones, being prepared to work with the patient 
during a mutually agreeable time when it is possible to listen to her 
problems without being HURRIED and to give support /counselling 
and other kinds of help. 
A careful and detailed history is essential before the examination of 
any patient. In addition to a good general history, focusing on the 
history of the presenting complaint (AVB) will allow you to 
customize the examination to elicit the appropriate signs and 
make an accurate diagnosis. 
It is important that a TEMPLATE is used for history taking as this 
prevents the omission of important points. 
Pregnancy in women of reproductive age; the possibility of 
pregnancy-related bleeding must always be considered in any 
patient presenting with abnormal vaginal bleeding. Conditions such 
as miscarriage, ectopic pregnancy, gestational trophoblastic 
disease and postpartum haemorrhage may present as a complaint 
related to abnormal menstruation. 
 In cases of reproductive age women presenting with abnormal 
vaginal bleeding the following template is suggested: 
Identifying information: 
Name / Occupation 
This can be an extension of her social history. Knowing the type 
of work the patient does (including the type of physical exercise 
entailed) something of her education and her community activities 
may assist in ascertaining the patient’s relationship to her entire 
environment. 
Age 
Knowledge of the patient’s age sets the tone for the complaint and 
the approach to the patient. At this stage a brief statement of the 
general nature and the duration of the main complaint can be 
taken.  Obviously, the problems and the approach to them vary at 
different stages in a woman’s life (pubescence, adolescence, 
childbearing years, and peri-and postmenopausal years). 
Last Normal Menstrual Period 
The date of the onset of the last normal menstrual period (LNMP) 
is important to define. A missed period, irregularities of the periods, 
erratic bleeding, or other abnormalities all imply certain events that 
are more easily diagnosed when the date of onset of the LNMP is 
established. 
 Gravidity and Parity 
The process of taking a brief obstetric (reproductive) history 
should be recorded as part of the gynaecological evaluation. A 
convenient symbol for recording the reproductive history is a 4-digit 
code denoting the number of term pregnancies, premature 
deliveries, abortions, and living children (TPAL). The number of 
abortions and the gestational ages at which they occurred may 
also be significant. Any abnormalities with pregnancy, labour or the 
puerperium may be high lighted. 
History of the presenting illness: 
The “chief” or presenting complaint is best elicited by asking the 
patient “What kind of problem are you having?” Each of the 
problems the patient is having must be obtained in detail by 
questioning regarding what exactly the problem is, the date and 
time of onset, weather the symptoms are abating or getting worse, 
the duration of the symptoms when they do occur and how these 
symptoms are related to or influence other aspects of her life. In 
case of A.V.B for example certain points should always be 
enquired about; the abnormal menstrual loss, pattern of bleeding 
(weather it is regular or irregular), any associated intermenstrual or 
contact “post coital” bleeding and weather this is a new event 
superimposed on her original presenting complaint, the amount of 
blood loss (weather it is more or less than usual), number of pads 
used per day, passage of clots or frank flooding—note however 
the appreciation of a woman’s blood loss is highly subjective and 
objective analysis based on history is very difficult. If there is any 
associated symptoms with her chief complaint such as pelvic pain 
 (the site, nature, its relations to the bleeding and weather there are 
any aggravating or relieving factors) masses (the site, associated 
tenderness, weather it is increasing in size and weather it is 
causing any symptoms not related to the genital tract; such as 
affecting her bowel or urinary habits) vaginal discharge (its 
amount, odour, colour, and the presence of blood staining). Any 
recent changes in appetite, weight gain or loss. 
Past History: 
Gynaecological 
The first item in the past gynaecological history is the usual 
menstrual history; age at menarche, interval between periods, 
and duration of flow, amount and character of the flow, degree of 
discomfort. 
A prior history of sexually transmitted disease (STD) needs to be 
detailed. Any history of treatment or admission for treatment of 
salpingitis, endometritis, or tubo-ovarian abscess must be carefully 
documented. Attempts to assess the impact of these processes in 
relation to ectopic pregnancy, infertility, and the type of 
contraception must be elicited. The occurrence of episodes of 
vaginitis/urinary tract infections should not be missed; their 
frequency and medications used to treat them should also be 
documented—note in the case of such infections it is important to 
detail weather or not it was a pathological situation or merely a 
misinterpreted physiological circumstance. 
 
 Sexual and Contraceptive History 
The sexual history should be an integral part of any gynaecological 
history. While taking the history the physician must be non-
judgemental and not embarrassed to ask direct questions.  
Questions that must be covered are; is she currently sexually 
active? Is the relationship satisfactory to her and, if not why not? Is 
there an associated history of discomfort, pain or bleeding during 
intercourse? 
Continuing with the history, it is important to elicit weather the 
patient is using or needs some form of contraception, her level of 
satisfaction with her chosen method should be determined. In 
patients taking oral contraceptives, the history should reflect the 
agent and the dose, whether there is great variation in the time of 
day she takes her pill, and any impact the pill has had on other 
physiological functions. It is also important during the remainder of 
the history and the physical examination to be meticulous about 
eliciting the presence (or not) of any factors, such as obesity, etc 
that may represent a contraindication to the patient’s current form 
of contraception. 
Medications 
Any medications, prescribed or otherwise, that are being taken or 
were being taken when the symptoms first occurred should be 
described. Particular attention must be directed to use of 
hormones, steroids, anticoagulants, and any other compounds 
likely to influence the reproductive tract. 
  
Medical / Surgical History 
It is important to discover history of priorly diagnosed medical or 
psychiatric illnesses and whether hospitalization was required. 
Particularly important are illnesses to major organ systems. It is 
also important to know whether there is a major endocrinopathy in 
the patient’s history. Notable weight gain or loss prior to the onset 
of the patient’s current symptoms should be detailed. Other 
important details may include when she had her last physical 
examination, including pelvic examination and Pap smear. The 
surgical history includes all operations; the dates performed, and 
associated postoperative or anaesthetic complications. 
Family History 
The patient’s family history must include the state of health of 
immediate relatives. In addition to listing these relatives, it is useful 
in cases where genetic illnesses may be apparent to record a 3-
generation pedigree. 
The incidence of familial heart disease, hypertensive renal or 
vascular disease, diabetes mellitus, vascular accidents and 
haematological abnormalities must be ascertained. If the patient 
has a problem with hirsutism or if she perceives excessive hair 
growth it is important to elicit whether anyone else in her family has 
the same distribution of hair growth. 
Familial history of breast or ovarian cancers is important to elicit 
since a close familial history may require additional testing and 
 close follow-up. It is important to relate the time of menopause in 
the mother or grandmother and to ascertain a history of 
osteoporosis.   
Physical examination 
The physical examination is most useful if it is conducted in an 
environment that is aesthetically pleasing to the patient. Adequate 
gowning and draping assist in the prevention of embarrassment. 
Often a physician's assistant conducts the patient to the dressing 
area and gives explicit instructions about what to take off and how 
to put on her gown and then may assist in draping the patient. 
A physician may have a female assistant remain in the examining 
room to assist when necessary, but whether or not she remains 
solely as a chaperone depends on local custom and the 
preference of the patient and the physician. A chaperone is not 
customarily or legally required, but the physician, male or female, 
must be selective in this matter and have an assistant present 
during the examination of an overly fearful or potentially seductive 
patient. If the patient wants her partner, relative, or a female friend 
to be present, the request should be honored unless, in the 
physician judgment, some impropriety might result or such an 
arrangement would interfere with the examination or with obtaining 
an accurate history. 
General examination 
If the gynecologist is the primary care physician for the patient, a 
general physical examination should be performed yearly or 
 whenever the situation warrants. A complete examination 
obviously provides more information, demonstrates the physician 
thoroughness, and establishes rapport with the patient. 
Vital signs 
As part of every examination –whether for a specific problem, 
routine annual examination, or a return visit for a previously 
diagnosed problem. Before she empties her bladder for the 
examination, it should be determined whether the urine will need to 
be sent for urinalysis, culture or pregnancy testing. The patient’s 
vital signs, height and weight should be documented.  
A general examination looking for stigmata of underlying systemic 
disease is important. It is essential to specifically look for signs of 
endocrine disorders; hirsutism, striae, thyroid enlargement or 
nodularity, skin pigment changes. An assessment of normal 
secondary sexual characteristics should be performed. Look for 
ecchymoses or petechiae, which may suggest an underlying 
coagulopathy. Palpation of the abdomen for liver enlargement and 
the presence of pelvic masses as well as palpation of regional 
lymph nodes should also be done routinely.  
The examination of the chest should include visual examination for 
any skin lesions and symmetry of movement. Auscultation and 
percussion of the lungs are important for excluding primary 
pulmonary problems such as asthma and pneumonia. The 
examination of the heart includes percussion for size and 
auscultation for arrhythmias and significant murmurs. 
 
 Abdominal examination 
The patient should be lying completely supine and relaxed; the 
knees may be slightly flexed and supported as an aid to relaxation 
of the abdominal muscles. Inspection should detect irregularity of 
contour or colour. Auscultation should follow inspection but 
precede palpation because the latter may change the character of 
intestinal activity. Palpation of the entire abdomen gently at first, 
then more firmly as indicated- should detect rigidity, voluntary 
guarding, masses and tenderness. If the patient complains of 
abdominal pain or if unexpected tenderness was elicited, the 
examiner should ask her to indicate the point of maximal pain or 
tenderness with one finger. Suprapubic palpation is designed to 
detect uterine, ovarian or urinary bladder enlargements. A painful 
area should be left until last for deep palpation; otherwise, the 
entire abdomen may be guarded voluntarily. As a final part of the 
abdominal examination, the physician should carefully check for 
any abnormality of the abdominal organs: liver, gallbladder, spleen, 
kidneys and intestines. In some instances, the demonstration of an 
abnormality of the abdominal muscle reflexes may be 
diagnostically helpful. Percussion of the abdomen should be 
performed to identify organ enlargement, tumour or ascites.  
Pelvic examination  
The pelvic examination is a procedure feared by many women and 
must be conducted in such a way as to allay her anxieties. A 
patient's first pelvic examination may be especially disturbing, so it 
is important for the physician to attempt to allay fear and to inspire 
confidence and cooperation. The empathic physician usually finds 
 that by the time the history has been obtained and a painless and 
non embarrassing general examination performed, a satisfactory 
gynaecologic examination is not a problem. Relaxing surrounding; 
a nurse or attendant chaperone if indicated; warm instruments; and 
a gentle, unhurried manner with continued explanation and 
reassurance are helpful in securing patient relaxation and 
cooperation. This is especially true with the women who has never 
had a pelvic examination before. In these patients a one-finger 
examination and a narrow speculum often are necessary. In some 
cases, vaginal examination is not possible; palpation of the pelvic 
structures by rectal examination is then the only recourse. 
Occasionally an ultrasound examination may be helpful 
ascertaining whether the pelvic organs are normal in size and 
configuration in patients from whom adequate relaxation of the 
abdominal muscles cannot be obtained. If a more definitive pelvic 
examination is essential, it can be performed with the patient 
anesthetized under general anaesthesia. 
External genitalia 
The pubic hair should be inspected for its pattern (masculine or 
feminine), for the nits of pubic lice, for infected hair follicles or for 
any other abnormality. The skin of the vulva, mons pubis and 
perineal area should be examined for evidence of dermatitis or 
discoloration. The glans clitoridis can be exposed by gently 
retracting the surrounding skin folds. The clitoris is at the ventral 
confluence of the 2 labia; it should be no more than 2.5 cm in 
length, most of which is subcutaneous. The major and minor labia 
are usually the same size on both sides, but a moderate difference 
in size is not abnormal. Small protuberances or subcutaneous 
 nodules may be either sebaceous cysts or tumours. External 
condylomata are often found in this area. The urethra, just below 
the clitoris, should be the same colour as the surrounding tissue 
and without protuberances. Normally, vestibular (Bartholin's) 
glands can be neither seen nor felt; thus enlargement may indicate 
an abnormality of this gland system. The area of vestibular glands 
should be palpated by placing the index finger in the vagina and 
the thumb outside and gently feeling for enlargement or 
tenderness. The perineal skin may be reddened as a result of 
vulval or vaginal infection. Scars may indicate obstetric lacerations 
or surgery. The anus should also be inspected at this time for the 
presence of haemorrhoids, fissures, irritation, or perianal infections 
(e.g. condylomata or herpes virus lesions). 
Hymen 
An unruptured hymen may present in many forms, but only a 
completely imperforate, cribriform, septate hymen is pathologic. 
After rupture, it also may be seen in various forms. 
Perineal Support 
To determine the presence of pelvic relaxation, the physician 
spreads the labia with two fingers and tells the patient to bear 
down. This will demonstrate urethrocele, cystocele, rectocele or 
uterine prolapse, although sometimes an upright position may be 
necessary to demonstrate significant prolapse.  
 Vaginal Examination 
The vagina should first be inspected with the speculum for 
abnormalities and to obtain a Pap smear before further 
examination. A speculum dampened with warm water but not 
lubricated is gently inserted into the vagina so that the cervix and 
fornices can be thoroughly visualized. After the Pap smear is 
prepared, the vaginal wall is again inspected as the speculum is 
withdrawn. The type of speculum used depends on the preference 
of the physician, but the most satisfactory instrument for the 
sexually active patient is the Pederson speculum, although the 
wider Graves speculum may be necessary to afford adequate 
visualization. For the patient with small introitus, the narrow-bladed 
Pederson speculum is preferable. When more than the usual 
exposure is necessary, an extra large Graves speculum is 
available. To visualize a child's vagina, a Huffman or nasal 
speculum, a large otoscope or a Kelly air cystoscope is invaluable. 
Next, the vagina is palpated; unless the patient’s introitus is too 
small, the index and middle fingers of either hand are inserted 
gently and the tissues palpated. The vaginal walls should be 
smooth, elastic and non-tender. 
Bimanual Examination 
The uterus and adnexal structures should be outlined between the 
two fingers of the hand in the vagina and the flat of the opposite 
hand, which is placed upon the lower abdominal wall. Gentle 
palpation and manipulation of the structures will delineate position, 
size, shape, mobility, consistency and tenderness of the pelvic 
 structures (except in the obese or uncooperative patient or in a 
patient whose abdominal muscles are taut as a result of fear or 
tenderness. Tenderness can be elicited either on direct palpation 
or on movement or stretching of the pelvic structures.  
Cervix: 
The cervix is a firm structure traditionally described as having the 
consistency of the tip of the nose. Normally it is round and 
approximately 3-4 cm in diameter. The external os is also round 
and virtually closed. Multiparous women may have an os that has 
been lacerated. An irregularity in shape or nodularity may be due 
to one or more Nabothian cysts. If the cervix is extremely firm, it 
may contain a tumour, even cancer. The cervix (along with the  
body of the uterus) normally is moderately mobile, so that it can be 
moved 2-4cm in any direction without causing undue discomfort 
(when examining a patient, it is helpful to warn her that she will feel 
the movement of her uterus but that ordinarily this manoeuvre is 
not painful). Restriction of mobility of the cervix or corpus often 
follows inflammation, neoplasia or surgery. 
Corpus of the uterus: 
The corpus of the uterus is approximately half the size of the 
patient’s fist and weighs approximately 70-90gm. It is regular in 
outline and not tender to pressure or moderate motion. In most 
women, the uterus is anteverted; in about 1/3 of women, it is 
retroverted and is a physiological finding. In certain cases of 
endometriosis or previous salpingitis, it may be that the tipped 
uterus is the result of adhesions caused by the disease process. 
 The uterus is usually described in terms of its size, shape, position, 
consistency and mobility. 
Adnexa: 
Adnexal structures (fallopian tubes and ovaries) can not be 
palpated in many overweight women, because the normal tube is 
only about 7mm in diameter and the ovary no more than 3cm in its 
greatest dimension. In very slender women, the ovaries nearly 
always are palpable and, in some instances, the oviducts are as 
well. Unusual tenderness or enlargement of any adnexal structure 
indicates the need for further diagnostic procedures; an adnexal 
mass in any women is an indication for investigation. 
Rectovaginal examination: 
At the completion of the bimanual pelvic examination, a 
rectovaginal examination should always be performed, especially 
after the age of 40. The well lubricated middle finger of the 
examining hand should be inserted gently into the rectum to feel 
for tenderness, masses or irregularities. When the examining 
finger has been inserted a short distance, the index finger can than 
be inserted into the vagina until the depth of the vagina is reached. 
It is much easier to examine some aspects of the posterior portion 
of the pelvis by rectovaginal examination than by vaginal 
examination alone. The index finger can now raise the cervix 
towards anterior abdominal wall, which stretches the uterosacral 
ligaments. This is not usually painful; if it causes pain-and 
especially if the finger in the rectum can palpate tender nodules 
along the uterosacral ligaments-endometriosis may be present. 
 Diagnostic Outpatient Procedures 
Certain diagnostic procedure may be performed in the out patient 
because complicated equipment and general anaesthesia are not 
required. Diagnostic out patient procedures may be classified for 
practical purposes into three main categories: 
1) LABORATORY PROCEDURES 
2) IMAGING TECHNIQUES 
3) TISSUE SAMPLING  
Diagnostic Laboratory Procedures 
Routine Procedures should be considered with periodic primary 
care visits. The frequency with which these tests are given should 
be at the discretion of the physician, based on risk factors and the 
presenting complaint. There are a number of laboratory 
investigations that may be relevant. The patient’s history and 
examination will guide the selection of various tests. 
Complete Blood Count: 
Is an essential investigation in a patient with abnormal vaginal 
bleeding. The CBC will include the haemoglobin concentration, 
haematocrit, total/differential white cell count as well as the platelet 
count. 
 Pregnancy Tests: 
Is also an essential investigation as these are reproductive age 
women and this article is concerning non pregnancy related 
conditions, hence exclusion of pregnancy related conditions 
that may be interpreted as abnormal vaginal bleeding is 
mandatory. 
Pregnancy tests depend on the detection of large amounts of the 
gonadotrophic hormone produced by the trophoblast. This is found 
in the maternal circulation and is excreted in maternal urine after 
implantation. Human chorionic gonadotrophin (hCG) is a 
glycoprotein. The alpha subunit is also found in other hormones 
(LH/FSH) but the beta subunit is specific for hCG. The test may be 
done on maternal blood early or maternal urine after four weeks of 
gestation. Immunochemical tests (day 35 after the LNMP), if the 
woman is pregnant her urine will contain hCG soon after 
implantation. When anti-hCG is added to the urine it combines with 
the hCG and is neutralized. The mixture is now tested for anti-hCG 
with a suitable indicator and if none is found the test is positive for 
pregnancy.     
Urine analysis: 
Urine analysis should be obtained in symptomatic patients and 
should include both gross and microscopic examination. A 
microscopic examination may reveal crystals or bacteria, but 
unless the specimen is taken in a manner that will exclude vaginal 
discharge, the presence of bacteria is meaningless. 
 
 Tests for vaginal infection: 
If abnormal vaginal discharge is present, a sample of vaginal 
discharge should be scrutinized. A culture is obtained by applying 
sterile cotton-tipped applicator to the suspected area and then 
transferring the suspected material to an appropriate culture 
media. Since this is inconvenient in the out patient, most 
laboratories supply a pre-packaged kit that allows the physician to 
put the cotton tipped applicator into sterile container, which is then 
sent to the laboratory. A Chlamydia swab should be obtained from 
the endocervix and sent for identification. The vaginal discharge 
can also be tested for the vaginal pH. An acidic pH of 4-5 is 
consistent with fungal infection, whereas an alkaline pH of 5.5-7 
suggests infections such as bacterial vaginosis and trichomonas. 
Often an endocervical infection may be perceived as a vaginal 
infection. Obtaining a swab for gonorrhoea and Chlamydia testing 
from the endocervix is warranted. 
Saline (Plain Slide): 
To demonstrate trichomonas vaginalis organisms, the physician 
mixes on a slide one drop of vaginal discharge with one drop of 
normal saline warmed to approximately body temperature. The 
slide should have a cover slip. If the smear is examined while it is 
warm, actively motile trichomonads can usually be seen. The 
saline slide can also be used to look for the fungus Candida 
albicans, which appear as segmented and branching filaments. 
The slide can be useful in looking for bacterial vaginosis by looking 
for “clue cells,” epithelial cells covered from edge to edge by short 
coccobacilli type bacteria. 
 Potassium Hydroxide: 
One drop of an aqueous 10% potassium hydroxide solution is 
mixed with one drop of vaginal discharge on a clean slide and 
covered with a cover slip. The potassium hydroxide dissolves 
epithelial cells and debris and facilitates the visualization of the 
mycelia of a fungus causing vaginal infection. The slide can be 
brought near the nose to see if the discharge has a “fishy” odour. 
This odour is strongly suggestive of bacterial vaginosis, a common 
vaginal infection associated with a mixed anaerobic bacterial flora. 
In addition, this same slide with a cover slip can be magnified with 
a microscope to visualize mycelia that that may have been hidden 
by debris with just the saline smear.  
Bacterial Infection:    
Bacterial infection may be present, especially if there is an 
ischemic lesion such as after radiation therapy for cervical 
carcinoma, or if a patient is suspected of having bacterial 
vaginosis, gonorrhoea or Chlamydia tracomatis infection. Material 
from the cervix, urethra or vaginal lesion may be smeared, stained 
and examined microscopically or the material may be cultured 
Thyroid Function Test:  
Is done when there is a suspicion of thyroid dysfunction 
(hypo/hyperthyroidism). 
Glucose Screening: 
Is done when suspicion arises about the likelihood of diabetes 
mellitus. This is usually achieved using an oral glucose tolerance 
 test. The normal fasting plasma glucose level is less than 5.8 
mmol/l. For an oral glucose tolerance test patients should fast 
overnight. Venous blood is taken for fasting blood glucose and a 
75 gram glucose drink is given. Further venous blood samples are 
taken after 1 hour and 2 hours. The WHO criteria for non-pregnant 
women are: diabetes fasting glucose > 7.8 mmol/l and/or a 2 hour 
level of > 11 mmol/l.  
Prolactin Levels:  
Hyperprolactinaemia may result in anovulation, which can cause 
abnormal uterine bleeding. The presence of galactorrhea should 
also be a warning to the possibility of an elevated prolactin level. 
The fern test can determine the presence or absence of ovulation 
or the time of ovulation. When cervical mucus is spread upon a 
clean, dry slide and allowed to dry in air, it may or may not assume 
a frond like pattern when viewed under the microscope (sometimes 
it can be seen grossly). The fern frond pattern indicates an 
estrogenic effect on the mucus without the influence of 
progesterone; thus, a non-frond like pattern can be interpreted as 
showing that ovulation has occurred.  
Coagulation Screen/Bleeding Time:  
Is important to request in case a bleeding disorder is suspected. 
They are numerous and are best tailored towards a proper history 
and physical examination. Cases where thrombocytopenia is 
suspected, a platelet count may be requested on a peripheral 
blood smear or if deemed necessary a bone marrow aspiration for 
cytology may be carried out. Coagulation tests include a 
 prothrombin time PT (expressed as a ratio compared to control—
International Normalized Ratio "INR"), thrombin time, partial 
thromboplastin time PTT or activated partial thromboplastin time 
APTT. 
Renal / Liver Function Tests: 
Should be requested if a systemic condition or malignancy is 
suspected. As regarding the renal profile, a large range of tests 
may be preformed ranging from urine microscopy/culture, 24 hour 
urinary protein collection, and creatinine clearance. Blood tests 
that may be of value include urea, electrolytes and, as with all 
malignant conditions (as well as conditions associated with chronic 
renal failure); a full blood count, erythrocyte sedimentation rate, 
and protein electrophoresis may be called for. 
Liver biopsies and blood tests are important in eliciting chronic 
hepatic impairment. Biochemistry tests may be normal or show 
raised plasma transaminases (AST, ALT) and alkaline 
phosphatase. Later, when the synthetic capability of the liver has 
been affected there may be a decreased plasma albumin, 
increased prothrombin time, billirubin and a simultaneous decrease 
in the blood glucose and sodium levels.         
 Cultures 
Urine: 
Studies have demonstrated that a significant number of women 
(3% of non pregnant and 7% of pregnant women) have 
asymptomatic urinary tract infections. Culture and antibiotic 
sensitivity testing are required for the diagnosis and a guide for the 
treatment of urinary tract infections. 
Reliable specimens of urine for culture often can be obtained by 
the “clean catch” method: the patient is instructed to cleanse the 
urethral meatus carefully with soap and water, to urinate for a few 
seconds to dispose of urethral contaminants, and then to catch a 
“mid-stream” portion of the urine. It is essential that the urine does 
not dribble over the labia, but this may be difficult in some patients 
to accomplish (such as circumcised patients). 
A more reliable method of obtaining a urine sample for culture is by 
sterile catheterization performed by the physician or nurse. 
However care must be exercised in a catheterization to guarantee 
that infection is not introduce by faulty technique. When performed 
correctly, catheterization rarely causes infection of the urinary tract. 
Urethral: 
Urethral cultures are indicated if a sexually transmitted disease is 
suspected. 
 
 
 Vaginal: 
A culture is usually unnecessary for the diagnosis of vaginal 
infection, since visual inspection or microscopic examination will 
usually enable the physician to make a diagnosis, e.g., curd like 
vaginal material that reveals mycelia (candidiasis). However, in 
questionable cases a culture should be obtained. 
Cervical: 
As in the case of the urethra, the usual indication for a cervical 
discharge culture is the suspected presence of a sexually 
transmitted disease. 
 Imaging Techniques 
Diagnostic Ultrasonography 
The principle imaging technique in gynaecology is diagnostic 
ultrasound. This is because it is inexpensive and can be performed 
in the clinic or by the bed side as part of the gynaecological 
examination. Traditionally, a gynaecological scan was performed 
with a trans-abdominal transducer, with the patient's distended 
bladder acting as a window to the pelvic organs. The majority of 
scans are now performed with a high frequency transvaginal probe 
which, because of its proximity to the pelvic organs, provides 
superior images. Furthermore, the avoidance of having to fill the 
bladder makes this also the preferred route of investigation among 
patients. The technique employs high frequency (3 – 7.5 mHz) low 
intensity pulsed sound wave which are transmitted through the 
abdomen or pelvis by an ultrasound transducer. 
It requires expertise and is now becoming a sub discipline within 
the field of both obstetrics and gynaecology.             
Colposcopy: 
The colposcopy is a binocular microscope used for direct 
visualization of the cervix. Magnification as high as 60x is 
available, but the most popular instrument in clinical use has a 
magnification that effectively bridges the gap between what can be 
seen by the naked eye and the microscope. 
 
Colposcopy does not replace other methods of diagnosing cervical 
abnormalities, but is instead an additional and important tool.  
 The two most important groups of patients that can benefit from its 
use are 1) patients with an abnormal Pap smear, 2) DES-exposed 
daughters; who may have dysplasia of the vagina or cervix. The 
colposcopist is able to see areas of cellular dysplasia and vascular 
or tissue abnormalities not visible otherwise, which makes it 
possible to select areas most appropriate for biopsy. Stains and 
other chemicals are also used to improve visualization. The 
colposcope has reduced the need for doing blind cervical biopsies 
for which the rate of finding abnormalities was low. In addition the 
necessity for doing cone biopsies, a procedure associated with a 
high morbidity rate has been greatly reduced. Thus the 
experienced colposcopist is able to make decisions about the most 
appropriate therapy in case of pathology largely based on what is 
seen through the colposcope. 
 
Hysteroscopy: 
This is the visual examination of the uterine cavity through a fibre 
optic instrument, the hysteroscope. In order to inspect the interior 
of the uterus with the hysteroscope the uterine cavity is inflated 
with solutions such as saline, glycine, and dextran or by carbon 
dioxide insufflation. Intravenous sedation and paracervical block 
are often adequate for hysteroscopy so long as prolonged 
manipulation is not required. 
 
Hysteroscopic applications include evaluation of abnormal uterine 
bleeding, removal of polyps and IUDs, resection of submucus 
myomas and endometrial ablation. Most of these therapeutic 
manoeuvres require extensive manipulation, so regional or general 
anaesthesia is required. 
 Hysteroscopy should be performed only by physicians with proper 
training. The tip of the instrument is inserted just beyond the 
cervical os and then advanced slowly, with adequate distension 
under direct vision. 
 
Hysteroscopy is often used in conjunction wit another operative 
procedure such as curettage or laparoscopy. Failure of 
hysteroscopy may be due to cervical stenosis, inadequate 
distension of the uterine cavity, bleeding or excessive mucus 
secretion. Perforation of the uterus at the fundus is one of the most 
common complications, but unless there is damage to a viscus or 
internal bleeding develops, surgical intervention and repair may not 
be required. Bleeding generally subsides, but fulguration following 
attempts to remove polyps or myomas may be required to stop 
bleeding in some cases. Parametritis or salpingitis, rarely noted, 
usually necessitates antibiotic therapy.  
 
Tissue Sampling 
Schiller Test for Neoplasia:  
Although colposcopy is more accurate, the Schiller test can be 
performed when cancer or precancerous changes of the cervix or 
vaginal mucosa is suspected. The suspect area is painted with 
Lugol's (strong iodine) solution; any portion of the epithelium that 
does not accept the dye is abnormal because of the presence of 
scar tissue, neoplasia and precursors, and columnar epithelium. 
Biopsy should be performed in this area if there is any suspicion of 
cancer.  
 Biopsy: 
Vulva and Vagina: 
For biopsy of vulva and vagina, a 1-2 % aqueous solution of a 
standard local anaesthetic solution can be injected around a small 
suspicious area and a sample obtained with a skin punch or sharp 
scalpel. Bleeding can usually be controlled by pressure or by 
Monsel's solution, but occasionally suturing is necessary. 
Cervix: 
Colposcopically directed biopsy is the method of choice for the 
diagnosis of cervical lesions, either suspected on visualization or 
indicated after an abnormal Pap smear. Colposcopy should reveal 
the full columnar-squamous “transformation zone” (TZ) at the 
juncture of the exocervix and endocervix. In addition, it may be 
advisable to sample the endocervix by curettage. Specific 
instruments have been devised for cervical biopsy and 
endocervical curettage. The cervix is less sensitive to cutting 
procedures than the vagina, so one or more small biopsies of the 
cervix can be taken with little discomfort to the patient. Bleeding 
usually is minimal and controlled with light pressure for a few 
minutes or by the use of Monsel's solution when colposcopy is not 
available. A “4-quadrant” biopsy of the squamocolumnar junction 
may be taken at 12, 3, 6 and 9 o’clock if colposcopy is not 
available. A Schiller test may often more quickly direct the 
physician to the area that should be biopsied. 
 
 Endometrium:  
Endometrial biopsy can be helpful in the diagnosis of ovarian 
dysfunction (e.g., infertility) and as a test for carcinoma of the 
uterine corpus. The endometrial biopsy may be performed with a 
Duncan curette or by passing any of several available hollow 
endometrial biopsy curettes into the uterine cavity and using 
suction to aspirate fragments of endometrium into the curette. 
Endometrial biopsy may be performed with the newer, flexible 
disposable cannulas, such as the Pipelle, which have replaced 
most metal curettes previously used. In fact, endometrial biopsies 
have dramatically reduced the need for doing formal dilatation and 
curettage since the accuracy of biopsy is nearly the same. Since 
the procedure causes cramping, the patient should be warned and 
advised to take a pain medication such as ibuprofen 1 hour prior to 
the procedure.  
 
 Methodology 
Approach 
This was an observational, descriptive study carried out in various 
outpatient clinics of different Khartoum Teaching Hospitals to 
answer two RESEARCH QUESTIONS : 1) the approach of doctors 
in gynaecological units at K.T.H’s towards reproductive age 
women presenting to out patient clinics with a complaint of non-
pregnancy related “Abnormal Vaginal Bleeding”. 
 
2) To highlight the problems faced by doctors in K.T.H’s O.P. 
clinics and the hindrances faced by them, which may offer 
obstacles in proper evaluation. 
 
In answering the first question, the study involved designing a 
TDCL which was taken from different text books and references, 
complying as much as possible with internationally recognized 
evidence based medicine. The theme of the TDCL was "a protocol 
on proper out patient evaluation (based on history, physical 
examination, and investigations) of reproductive age women 
presenting with non-pregnancy related A.V.B. 
 
Doctors who evaluated the patients were observed to what degree 
they adhered to the TDCL. For ethical purposes the doctors were 
told that they were being observed, but the TDCL was not shown 
to them. 
In answering the second question, at the end the doctors who 
participated in the study were given a QUESTIONNAIRE to be 
 filled out by them, and the main theme of the questionnaire was 
"What are the main hindrances and obstacles faced by doctors in 
government teaching hospitals in proper out patient evaluation of 
reproductive age women c/o non- pregnancy related A.V.B.?" 
 
The main aim of the questionnaire was to gather different opinions 
and ideas as to how the quality of care offered to this group of 
women could be improved. 
 
 
Study Type 
Observational, descriptive, prospective, cross sectional, hospital 
based study. 
 
 
Study Area 
Different outpatient clinics associated with various Khartoum 
Teaching Hospitals (Khartoum Teaching Hospital, Ribat University 
Teaching Hospital, Omderman Teaching Hospital). 
 
 
Study Period 
This study was conducted from a period of June to September 
2004. 
 
Research tools 
1) Observations. 
 2) Direct standard “Template Designed Check List (TDCL)”  
3) Questionnaire based interviews with doctors dealing with 
the women presenting with Abnormal Vaginal Bleeding. 
 
Sampling / Data Collection 
Sampling Technique 
Regarding the collection of the patients who participated in the 
study there was a total coverage of all the patients who presented 
to the out patient department, provided that they fitted the inclusion 
criteria of the "patient target population". 
 
As regards the doctors who participated in the study, random 
sampling was used, also provided that they met the inclusion 
criteria of the "doctors target population". 
  
Sample Size 
A total of 36 doctors (meeting the inclusion criteria) participated in 
this study, and were observed to what extent they adhered to the 
TDCL in the evaluation of a total of 86 patients, meeting the 
inclusion criteria. 
 
 Target Population 
Two different populations were used in this study: 
DOCTORS: 
This included doctors working in the various out patient clinics of 
different K.T.H.'s. 
The inclusion criteria included: 
1) Registrars or medical officers working in the field of 
obstetrics and gynaecology. 
2) No emphasis was placed upon the degree of experience 
(seniority) of these doctors.  
PATIENTS: 
The patients included in this study were women presenting to 
different out patient clinics of various K.T.H.'s, with a complaint of 
A.V.B. 
The inclusion criteria included: 
1) The women were to be of reproductive age. 
2) The A.V.B. was to be non-pregnancy related. 
 
Data Analysis  
The data collected was analyzed by Mr. Mohammed Hassan MSc 
Statistical science at Ribat University, College of Computer Studies 
using the computerized Statistical Package for Social Sciences 
"SPSS".  
 
Data Presentation    
Tables and graphs were used in the interpretation of the statistical 
result. 
 Results 
 
The results of this study are divided into two main themes. The first 
reflects the observations to the degree of adherence 
they had to the TDCL, made while the doctors were 
conducting the evaluation of the target group of patients. The 
degree of adherence they had to the TDCL was statistically 
analysed and were graphically represented. Each group of graphs 
were placed under charts, with a major heading, coinciding with 
main aspects of the TDCL. 
 
In Chart (1), reflecting collection of biodata, the doctors were seen 
to be adherent in taking the name and age of the patients, but a 
significant majority missed the parity of a patient (a protocol of 
significance in the history taking of any previously parous 
gynaecological patient). 
 
Chart (2), reflects collection of data regarding the history of the 
presenting complaint. Here the response was also not up to the 
mark in varying degrees in different aspects. 
 
Chart (3), reflects collection of data regarding the gynaecological 
history of the patient. Attention was drawn to a significant failure 
response in enquiring about the age of onset of the patient's 
menarche. 
Chart (4), reflects collection of data regarding the patient's sexual 
and contraceptive history. Here the percentage of response in 
evaluation of this history was markedly deficient. 
  
Chart (5), reflects collection of data regarding any past medical, 
surgical or relevant family history. A severe deficiency was noted in 
all the aspects of this particular stem of the history taking. 
 
Chart (6), reflects collection of data regarding systemic enquiry. 
Apart from asking about micturation habits, the rest of the enquiry 
was almost ignored. 
 
Chart (7), reflects conduction of a proper general physical 
examination. Thyroid examination and elicitation of evidence of 
bleeding tendencies was missed by a significant number of the 
doctors. 
 
Chart (8), reflects conduction of a proper abdominal examination. 
A severe deficiency in the response rate was observed by the 
majority of the doctors. 
 
Chart (9), reflects conduction of a proper inspection of the lower 
genital tract (with or without) using sterile speculums. Here the 
response rate did not exceed half of the expected results.  
 
Chart (10), reflects conduction of a proper bimanual pelvic 
examination of the upper genital tract. Here there was also a 
failure in the response rate by a significant majority.  
Chart (11), reflects the requisition of appropriate, basic laboratory 
investigations. The response rate was high, although it was 
anticipated that the urine test for pregnancy was not to be missed 
by any of the doctors. 
  
Chart (12), reflects the requisition of appropriate imaging studies. 
It was observed that there was an overzealous request for 
ultrasonographic studies. 
 
Chart (13), reflects the requisition of appropriate tissue sampling. 
The majority, who requested, did so by warranting a dilatation and 
curettage.  
 
Chart (14), reflects the proportion of doctors who sent the patients 
to referral clinics for senior consultation. There was not very much 
difference in those who opted to do so and those who did not. 
 
The second was a representation of the questionnaire 
distributed amongst the doctors participating in the study, 
regarding their opinions about the main hindrances and obstacles 
faced by them in proper out patient evaluation of this group of 
women. 
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 Representation of the doctors’ opinions highlighting the main hindrances & 
obstacles faced by them in government teaching hospital in proper outpatients 
evaluation of this group of women  (N=36) 
 
No Questions % 
1 Is there an extremely large number of patients attending a SINGLE out patient ANTENATAL / 
GYNAECOLOGICAL clinic? 
100% 
2 Is the patient to available staff RATIO too large, such that by the end of the day both patients 
and staff become mentally exhausted? 
88.9% 
3 Is there a problem related to the level of education (literacy rate) with the compliance of the 
patients? 
88.9% 
4 Do you feel that the patient's compliance may sometimes be affected by the socioeconomic 
status? 
77.8% 
5 Does this sometimes cause you to bypass some important tests which may be required? 55.6% 
6 Do you agree that the patient's compliance and education of the severity of the problem (if it is 
so) is an essential component of the outcome of your evaluation and management? 
66.7% 
7 Do you agree that if your  investigations and work up would be tailored to a proper HISTORY 
and PHYSICAL EXAMINATION(although this may take a bit of an extra effort from your 
side) based on an evidence based protocol you would be more EFFICIENT and COST 
EFFECTIVE and as a result your patient’s compliance and hence your management would 
improve? 
55.6% 
8 Would this give you the satisfaction that you have improved the quality of your patient's life 
and hence helped the community by reducing morbidity and mortality associated with this 
presenting complaint? 
44.4% 
9 Do you sometimes think that the out patient clinic is deficient (or totally lacking) cheap 
diagnostic tools and instruments that may be essential in proper examination and evaluation? 
100% 
10 If the answer to question 9 is "yes" then can you suggest any of the instruments that come to 
your mind 
100% 
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 Discussion 
 
Regarding the history taking portion of the TDCL, it was found that 
a significant proportion of doctors missed inquiring about the use of 
contraception and the type of contraceptive used ( only 25.6%) 
inquired about this. Similarly, (only 27.9%) of them asked about 
history suggestive of thyroid disease. It was astonishing to note 
that 9.3%, 2.3%, 2.3% and 14% asked questions implying that they 
were searching for suggestions of a personal history of 
hypertension, known bleeding disorders, whether the patient was 
on any sort of anticoagulant therapy and a family history of pelvic 
malignancies respectively.  
 
Similarly, with regards to the likelihood of neoplasms of the genital 
tract (16.3%) inquired about any recent change in appetite (or 
weight gain / loss). (9.3%) asked about any recent change in bowel 
habits.  
 
A conclusion regarding missing these points can most probably be 
attributed not to the lack of knowledge of the questions per se, but 
can be illustrated by referring to the results of the graphical 
analysis of the questionnaire's questions 1 – 4 and question 6 
where the significant majority of them answered yes to the 
questions given to them. Please refer to the table and graphical 
representation of the questionnaire at page 66 where 100%, 
88.9%, 88.9%, 77.8% and 66.7% agreed that these opinions were 
obstacles and hindrances truly faced by them respectively.  
 
 It is clearly understandable that an overcrowded 24 hour duty, 
were the majority of the patients presenting are of a low 
socioeconomic status and of low literacy rates, tends to cause a 
marathon like history taking and there is no doubt that when 
hurrying a history, any doctor is bound to miss important points 
which may lead to omission of key factors that may narrow down 
the differential diagnosis and hence tailoring the rest of the 
evaluation towards a shorter list of differential diagnosis which will 
definitely streamline them in a proper direction. 
 
With regards the physical examination of the TDCL, 4.7% of the 
doctors performed a proper abdominal examination with the aim of 
eliciting pelviabdominal masses or organomegaly. Of these 4.7%, 
only 16.3% took time to emphasize whether the detected mass 
showed features of tenderness on superficial or deep palpation. 
 
Regarding inspection of the genital tract for evidence of pathology, 
it was noticed that the speculum examination was done after a 
bimanual pelvic examination (which should actually be done before 
a bimanual pelvic examination according to internationally 
standardized protocols so as not to introduce infection or change 
cellular cytology especially when biopsies of these areas are 
demanded).  
 
A speculum assisted inspection was performed of the cervix in 
51.3% and of the vaginal walls in 53.5%. When asked why the 
vaginal walls and cervix were not emphasized as a routine in the 
rest of the patients, it was justified by a significant majority of them, 
that they were attempting to take a high vaginal swab for culture 
 and sensitivity and were not actually trying to inspect the lower 
genital tract. The high vaginal swab was taken if the patient's 
A.V.B. was associated with vaginal discharge or after a urine 
general examination, requested by 81.4% of the doctors coinciding 
with the fact that 86% of the doctors asked about history 
suggestive of UTI (micturation). A significant majority of the doctors 
requested the urine general examination just on the basis that the 
A.V.B. was associated with burning micturation (it should be 
remembered that UTI is not always suggestive of Pelvic 
Inflammatory Disease). 
 
When observed during the bimanual pelvic examination which was 
performed by a high proportion of the doctors (although it should 
have been performed by the total number of doctors), 74.5% 
commented upon the uterine corpus / cervix; 74.5% commented 
on the fornixes and 74.4% were trying to identify adnexal masses 
or tenderness. 
 
Although it was mentioned before hand, that the target sample 
were reproductive age women with a complaint of non pregnancy 
related A.V.B., unexpectedly, only 81.4% requested a urine test for 
hCG. 
 
The above mentioned factors regarding the bimanual pelvic 
examination and the request for hCG were expected to be 100%. 
Contrary, at the other extreme, 93% requested an ultrasound scan 
which has the tendency to show either the presence or absence of 
a gestation as well as pelvic pathologies. As shown by question 7 
of the Questionnaire, only 55.6% agreed that if your investigations 
 and workup would be tailored to a proper history and physical 
examination (though this may take a bit of an extra effort from your 
side) supported by evidence based protocols you would be more 
efficient and cost effective. Immediate request of an ultrasound just 
to bypass this extra effort is not justifiable and shows that this is 
indiscriminate use of this expensive, expertise requiring and not 
always available imaging technique. Why pay more for less? 
 
When tissue sampling was requested, 97.7% subjected the 
patients for dilatation and curettage for biopsy, 14.9% sent the 
patients for hysterscopically directed biopsies and 53.5% sent the 
patients for referral clinics for senior opinion. Questions 2, 6, 7 and 
8 of the Questionnaire suggests that mental exhaustion and lack of 
satisfaction of improving the quality of your patients' life allowed 
the doctors either to try and help them by sending them for the 
above mentioned more appropriate and favourable circumstances. 
 Conclusion 
 
1. A number of significant points were missed in the history taking. 
 
2. The examination was found to be deficient regarding the 
thyroid, abdominal and a proper speculum examination. 
 
3. The urine testing for pregnancy was missed by a significant 
percent of the doctors. 
 
4. There was found to be an overzealous and sometimes uncalled 
for, use of ultrasonography. 
 
5. Lack of simple, cheap, diagnostic facilities; deficiency of doctors 
and other trained paramedical staff; the fact that multiple 
activities were being conducted at the same time, were found to 
be the major obstacles/hindrances faced by the doctors.    
 
 Recommendations 
 
1. The presence of additional trained staff is essential. 
 
2. Presence of enough speculums and other cheap diagnostic 
tools and instruments such as proper illumination, disposable 
gloves and proper lab facilities within the hospital setup are 
suggested. 
 
3. The presence hospital setup ultrasound, hysteroscope and the 
presence of expertise available at all times would help in more 
efficient, cost effective offering early diagnosis and hence 
prompt treatment, with the result that quality of care offered to 
this group of patients may be improved. 
 
4. Sticking to the TDCL would be more cost effective and efficient 
especially in a country where poverty deems.          
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 Template Designed Check List 
 
History 
Biodata: 
Q) 1 Serial no (Name) 
Q) 2 Age: 
Q) 3 Parity: 
 
History of presenting complaint: 
Q) 1 Abnormal menstrual loss (menstrual complaint): 
Q) 2 Pattern of bleeding (regular/irregular): 
Q) 3 Amount of blood loss: 1) greater or less than usual 
                                            2) Passage of clots or flooding  
                                            3) no. of sanitary pads/ tampons used 
Q) 4 Any associated intermenstrual / post contact bleeding 
Q) 5 Any associated pelvic pain (dysmenorrhoea / dyspareunia) 
Q) 6 Any associated vaginal discharge:  1) Amount 
                                                                2) Colour 
                                                                 3) Odour 
                                                                 4) Presence of blood 
 
Gynaecological history: 
Q) 1 Age of menarche: 
Q) 2 Usual duration of each period and length of cycle: 
Q) 3 First day of the last normal period: 
Q) 4 Any previous gynaecological treatments or surgery: 
 
Sexual and contraceptive history: 
 Q) 1 History during intercourse of:  1) pain 
                                                       2) discomfort 
                                                        3) bleeding 
Q) 2 The use of contraception and the type of contraception used: 
 
Past medical and surgical history: 
Q) 1 Thyroid disease: 
Q) 2 Diabetes mellitus: 
Q) 3 Hypertension 
Q) 4 Known bleeding disorders: 
Q) 5 On any anticoagulant therapy:   
 
Family history: 
Any positive history of  pelvic malignancies. 
 
Systemic enquiry: 
Q) 1 Appetite (recent weight gain/loss): 
Q) 2 Bowels 
Q) 3 Micturation 
 
Examination 
General physical examination: 
1) Vital signs 
2) Pallor 
3) Thyroid disease 
4) Purpura / petichial haemorrhages /bleeding gums/bruising 
 
Abdominal examination: 
 1) Abdominal mass 
2) Abdominal tenderness 
Pelvic examination: 
Inspection (with/without use of speculum) of the:  
1) Vulva 
2) Cervix 
3) Vaginal walls  
Bimanual pelvic examination of the: 
1) Uterine corpus/cervix 
2) Fornixes 
3) Adnexae 
 
Investigations 
Laboratory tests: 
1) Haemoglobin 
2) Urine test for hCG 
3) Urine general 
Imaging studies: 
1) Ultrasound scan (particular type) 
2) Others 
Tissue sampling: 
1) Dilatation and curettage 
2) Hysteroscopically directed biopsy 
 
Consultation for senior opinion 
 
 Questionnaire 
 
What are the main hindrances and obstacles faced by doctors in 
government teaching hospitals in proper out patient evaluation of 
reproductive age women  c/o non pregnancy related A.V.B.? 
 
1) Is there an extremely large number of patients attending a 
SINGLE out patient ANTENATAL//GYNAECOLOGICAL 
clinic? 
2) Is the patient to available staff RATIO too large, such that by 
the end of the day both patients and staff become mentally 
exhausted? 
3) Is there a problem related to the level of education (literacy 
rate) with the compliance of the patients? 
4) Do you feel that the patient’s compliance may sometimes be 
affected by the socioeconomic status? 
5) Does this sometimes cause you to bypass some important 
tests which may be required? 
6) Do you agree that the patient’s compliance and education of 
the severity of the problem (if it is so) is an essential 
component of the outcome of your evaluation and 
management? 
7) Do you agree that if your  investigations and work up would 
be tailored to a proper HISTORY and PHYSICAL 
EXAMINATION(although this may take a bit of an extra effort 
from your side) based on an evidence based protocol you 
would be more EFFICIENT and COST EFFECTIVE and as a 
 result your patient’s compliance and hence your 
management would improve?  
8)  Would this give you the satisfaction that you have improved 
the quality of your patient’s life and hence helped the 
community by reducing morbidity and mortality associated 
with this presenting complaint? 
9) Do you sometimes think that the out patient clinic is deficient 
(or totally lacking) cheap diagnostic tools and instruments 
that may be essential in proper examination and evaluation? 
10) If the answer to question 9 is “yes” then can you 
suggest any of the instruments that come to your mind? 
 
 
